Biotech Distilled
Substack ↗
Subscribe
Subscribe
Substack ↗
About
Research
Areas
Modalities
Phases
Targets
Catalysts
Track record
Movers
The Lead Compound
Home
›
Targets
› DMPK
DMPK
(3 companies · 3 programs)
Companies with an active program directed at DMPK.
Dyne Therapeutics, Inc.
DYN
zeleciment basivarsen
— Myotonic Dystrophy Type 1
Phase 3
PepGen Inc.
PEPG
PGN-EDODM1
— Myotonic Dystrophy Type 1
Phase 2
Sarepta Therapeutics, Inc.
SRPT
SRP-1003
— Myotonic Dystrophy Type 1
Phase 1